InSimili s.r.l. is a private biotechnology company that aims to bring to the market a patented technology, which will revolutionize the drug selection process.
Our product can recreate the microenvironment of pathological and physiological conditions in standard cell culture containers.
Our solution bridges the gap between patients and in vitro studies, enabling a better evaluation of the real efficacy of innovative treatments.
By selecting better drug candidates early, pharmaceutical companies can minimize the risk of failures in the clinical phases, saving time and billions of dollars.
Company Details
- Employees
- 4
- Founded
- 2021
- Address
- Viale Giuseppe Fanin, Bologna,emilia Romagna 40127,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.insimili.com
- Keywords
- Milan.
- HQ
- Bologna, Emilia Romagna
Insimili Questions
Insimili's website is http://www.insimili.com
Insimili's LinkedIn profile is https://it.linkedin.com/company/insimili
Insimili has
4 employees.
View email and phone details for 4
employees at Insimili.
Insimili's industry is
Biotechnology Research
Insimili's top competitors are
Equixly Api Security,
Exoheal,
Billd,
Planeto,
The Paac,
Magnitude Biosciences Ltd,
Mopso,
Effetto Venturi Sa,
Semarion,
Mynerva Ag.
Insimili's categories are Biotechnology Research
Insimili's founding year is 2021
